Clinical Trials Browser

Active not recruiting × Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) × Imatinib Mesylate × Clear all

NCT03589326 2025-11-26

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

Phase 3 Active not recruiting

245 enrolled 15 charts 2 FDA

LymphoidOther hematologic neoplasm

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)